These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 35615883)

  • 1. Functional Mechanism of Ginsenoside Compound K on Tumor Growth and Metastasis.
    Liu J; Wang Y; Yu Z; Lv G; Huang X; Lin H; Ma C; Lin Z; Qu P
    Integr Cancer Ther; 2022; 21():15347354221101203. PubMed ID: 35615883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbial deglycosylation and ketonization of ginsenoside by Cladosporium cladosporioide and their anticancer activity.
    Jin Y; Jung SY; Kim YJ; Lee DY; Aceituno VC; Wang C; Yang DC
    Antonie Van Leeuwenhoek; 2016 Feb; 109(2):179-85. PubMed ID: 26558793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional mechanism of Ginsenosides on tumor growth and metastasis.
    Chen T; Li B; Qiu Y; Qiu Z; Qu P
    Saudi J Biol Sci; 2018 Jul; 25(5):917-922. PubMed ID: 30108441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of ginsenoside Rd in the ginseng extraction residue by fermentation with lingzhi (Ganoderma lucidum).
    Hsu BY; Lu TJ; Chen CH; Wang SJ; Hwang LS
    Food Chem; 2013 Dec; 141(4):4186-93. PubMed ID: 23993604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of biotransformation and pharmacology of ginsenoside compound K.
    Yang XD; Yang YY; Ouyang DS; Yang GP
    Fitoterapia; 2015 Jan; 100():208-20. PubMed ID: 25449425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside Compound K Induces Ros-Mediated Apoptosis and Autophagic Inhibition in Human Neuroblastoma Cells In Vitro and In Vivo.
    Oh JM; Kim E; Chun S
    Int J Mol Sci; 2019 Sep; 20(17):. PubMed ID: 31480534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of ginsenoside metabolites on the 5-HT3A receptor-mediated ion current in Xenopus oocytes.
    Lee BH; Jeong SM; Lee JH; Kim DH; Kim JH; Kim JI; Shin HC; Lee SM; Nah SY
    Mol Cells; 2004 Feb; 17(1):51-6. PubMed ID: 15055527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of ginsenoside compound K by microbial cell factory using synthetic biology-based strategy: a review.
    Li F; Chen MM; Zhang HM; Wu QP; Han YB
    Biotechnol Lett; 2023 Feb; 45(2):163-174. PubMed ID: 36550334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment.
    Zhang Y; Qiu Z; Qiu Y; Su T; Qu P; Jia A
    Integr Cancer Ther; 2019; 18():1534735419886655. PubMed ID: 31729239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of Ginsenoside Compound K From a Compound K Fermentation Product, CK-30, and From Red Ginseng Extract in Healthy Korean Subjects.
    Ban MS; Kim Y; Lee S; Han B; Yu KS; Jang IJ; Chung HK; Lee S
    Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1358-1364. PubMed ID: 33884767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginsenoside Compound K Assisted G-Quadruplex Folding and Regulated G-Quadruplex-Containing Transcription.
    Zhang Y; Qiu Z; Zhu M; Teng Y
    Molecules; 2021 Dec; 26(23):. PubMed ID: 34885920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protopanaxadiol-type ginsenoside hydrolases and their application in the preparation of ginsenoside Compound K: a review].
    Yang W; Gu Q; Yu X
    Sheng Wu Gong Cheng Xue Bao; 2023 Mar; 39(3):978-992. PubMed ID: 36994566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the antitumor mechanism of ginsenosides Rg3.
    Liu Z; Liu T; Li W; Li J; Wang C; Zhang K
    Mol Biol Rep; 2021 Mar; 48(3):2639-2652. PubMed ID: 33661439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red ginseng and cancer treatment.
    Wang CZ; Anderson S; DU W; He TC; Yuan CS
    Chin J Nat Med; 2016 Jan; 14(1):7-16. PubMed ID: 26850342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Minor Ginsenoside CK from Major Ginsenosides by Biotransformation and Its Advances in Targeted Delivery to Tumor Tissues Using Nanoformulations.
    Murugesan M; Mathiyalagan R; Boopathi V; Kong BM; Choi SK; Lee CS; Yang DC; Kang SC; Thambi T
    Nanomaterials (Basel); 2022 Sep; 12(19):. PubMed ID: 36234555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of the Effects and Mechanisms of Ginsenoside Compound K on Myelosuppression.
    Han J; Wang Y; Cai E; Zhang L; Zhao Y; Sun N; Zheng X; Wang S
    J Agric Food Chem; 2019 Feb; 67(5):1402-1408. PubMed ID: 30629411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer property of ginsenoside Rh2 from ginseng.
    Li X; Chu S; Lin M; Gao Y; Liu Y; Yang S; Zhou X; Zhang Y; Hu Y; Wang H; Chen N
    Eur J Med Chem; 2020 Oct; 203():112627. PubMed ID: 32702586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advances in the study of derivatization of ginsenosides and their anti-tumor structure-activity relationship].
    Cao M; Yu HS; Song XB; Ma BP
    Yao Xue Xue Bao; 2012 Jul; 47(7):836-43. PubMed ID: 22993845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenosides, ingredients of the root of Panax ginseng, are not substrates but inhibitors of sodium-glucose transporter 1.
    Gao S; Kushida H; Makino T
    J Nat Med; 2017 Jan; 71(1):131-138. PubMed ID: 27619505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.